CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine
Gu Hyun Jung, Su Jeong You
Clin Exp Pediatr. 2019;62(8):312-316.   Published online April 11, 2019
DOI: https://doi.org/10.3345/kjp.2019.00017

Excel Download

Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine
Korean Journal of Pediatrics. 2019;62(8):312-316   Crossref logo
Link1 Link2 Link3

IS ESTABLISHING AN APPROPRIATE BLEEDING RISK PROFILE IN ELDERLY PATIENTS TREATED WITH LOW-MOLECULAR-WEIGHT HEPARINS NEEDED?
Journal of the American Geriatrics Society. 2005;53(10):1834-1836   Crossref logo
Link1 Link2

Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy
Seizure. 2015;31:149-154   Crossref logo
Link1 Link2

Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal®) on a named-patient basis
Epilepsy Research. 1994;19(1):79-85   Crossref logo
Link1 Link2

Safety profile of oxcarbazepine: Results from a prescription-event monitoring study
Epilepsia. 2010;51(5):818-829   Crossref logo
Link1 Link2

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
Korean Journal of Pediatrics. 2019;62(8):299-300   Crossref logo
Link1 Link2 Link3

Perioperative Evaluation of Patients with Hematologic Disorders
Medical Management of the Surgical Patient. 2008;117-156   Crossref logo
Link1 Link2

Infections in Patients with Hematologic Malignancies Treated with Monoclonal Antineoplastic Therapy
Principles and Practice of Cancer Infectious Diseases. 2011;47-66   Crossref logo
Link1

732 Pathological T2b and T2c subgrouping may not be needed for predicting biochemical relapse in patients treated by radical prostatectomy
European Urology Supplements. 2014;13(1):e732-e732b   Crossref logo
Link1 Link2

Therapeutic Apheresis for Hematologic Emergencies
Hematologic Challenges in the Critically Ill. 2018;341-361   Crossref logo
Link1